Golden Ten Data reported on April 21 that Zhifei Biotech released the first quarter report of 2025, with an operating income of 2.374 billion yuan, a year-on-year decrease of 79.16%, and a net loss attributable to shareholders of listed companies of 305 million yuan, a year-on-year profit turned into a loss. The main reason was that the marketing efforts did not meet expectations and the sales revenue decreased.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Zhifei Biological: Net loss of 305 million yuan in the first quarter, turning from profit to loss year-on-year.
Golden Ten Data reported on April 21 that Zhifei Biotech released the first quarter report of 2025, with an operating income of 2.374 billion yuan, a year-on-year decrease of 79.16%, and a net loss attributable to shareholders of listed companies of 305 million yuan, a year-on-year profit turned into a loss. The main reason was that the marketing efforts did not meet expectations and the sales revenue decreased.